These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12169040)

  • 1. Desloratadine demonstrates dose proportionality in healthy adults after single doses.
    Gupta S; Banfield C; Affrime M; Marco A; Cayen M; Herron J; Padhi D
    Clin Pharmacokinet; 2002; 41 Suppl 1():1-6. PubMed ID: 12169040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of race and sex on single and multiple dose pharmacokinetics of desloratadine.
    Affrime M; Banfield C; Gupta S; Cohen A; Boutros T; Thonoor M; Cayen M
    Clin Pharmacokinet; 2002; 41 Suppl 1():21-8. PubMed ID: 12169043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bioavailability of desloratadine is unaffected by food.
    Gupta S; Banfield C; Affrime M; Marbury T; Padhi D; Glue P
    Clin Pharmacokinet; 2002; 41 Suppl 1():7-12. PubMed ID: 12169041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic profile of desloratadine in healthy adults, including elderly.
    Affrime M; Gupta S; Banfield C; Cohen A
    Clin Pharmacokinet; 2002; 41 Suppl 1():13-9. PubMed ID: 12169042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
    Banfield C; Gupta S; Marino M; Lim J; Affrime M
    Clin Pharmacokinet; 2002; 41(4):311-8. PubMed ID: 11978146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of clinically relevant interaction between desloratadine and erythromycin.
    Banfield C; Hunt T; Reyderman L; Statkevich P; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():29-35. PubMed ID: 12169044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study.
    Solans A; Carbó ML; Peña J; Nadal T; Izquierdo I; Merlos M
    Clin Ther; 2007 May; 29(5):900-908. PubMed ID: 17697908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole.
    Banfield C; Herron J; Keung A; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():37-44. PubMed ID: 12169045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years.
    Salmun LM; Herron JM; Banfield C; Padhi D; Lorber R; Affrime MB
    Clin Ther; 2000 May; 22(5):613-21. PubMed ID: 10868558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers.
    Nomeir AA; Mojaverian P; Kosoglou T; Affrime MB; Nezamis J; Rodwanski E; Lin CC; Cayen MN
    J Clin Pharmacol; 1996 Oct; 36(10):923-30. PubMed ID: 8930779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy men.
    Villacampa J; Alcántar F; Rodríguez JM; Morales JM; Herrera J; Rosete R
    Clin Ther; 2003 Aug; 25(8):2225-32. PubMed ID: 14512130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.
    Gupta S; Banfield C; Kantesaria B; Marino M; Clement R; Affrime M; Batra V
    Clin Ther; 2001 Mar; 23(3):451-66. PubMed ID: 11318079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males.
    Kosoglou T; Radwanski E; Batra VK; Lim JM; Christopher D; Affrime MB
    Clin Ther; 1997; 19(5):1002-12. PubMed ID: 9385487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose linearity of lacidipine pharmacokinetics after single and repeated oral doses in healthy volunteers.
    Da Ros L; Squassante L; Milleri S
    Clin Pharmacokinet; 2003; 42(1):99-106. PubMed ID: 12489980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tablets.
    Adams MP; Ahdieh H
    Drugs R D; 2005; 6(2):91-9. PubMed ID: 15777102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.
    Noehr-Jensen L; Damkier P; Bidstrup TB; Pedersen RS; Nielsen F; Brosen K
    Eur J Clin Pharmacol; 2006 Jun; 62(6):437-45. PubMed ID: 16770647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.